Side-by-side comparison of AI visibility scores, market position, and capabilities
Santa Clara semiconductor (NASDAQ: AMD) at $268B market cap; OpenAI 6 GW Instinct GPU partnership ($100B+ over 4 years, Oct 2025), Q3 2025 data center $4.3B revenue competing with NVIDIA for AI accelerator market.
Advanced Micro Devices, Inc. (AMD) is a Santa Clara, California-based semiconductor company — publicly traded on NASDAQ (NASDAQ: AMD) as an S&P 500 component — designing CPUs, GPUs, FPGAs, and AI accelerators for data centers, gaming, PCs, and embedded systems with approximately 26,000 employees and a market capitalization of approximately $268 billion (June 2024). In Q3 2025, AMD's data center segment revenue reached $4.3 billion, driven by Instinct AI accelerators and EPYC server processors. In October 2025, AMD announced a multibillion-dollar strategic partnership with OpenAI — OpenAI will deploy 6 gigawatts of AMD Instinct GPUs, expected to generate over $100 billion in new revenue for AMD over four years, with OpenAI receiving a warrant for up to 160 million AMD shares (potential ~10% stake). AMD stock surged 23.71% on the announcement. CEO Dr. Lisa Su (since 2014) led one of Silicon Valley's most celebrated turnarounds, growing AMD stock from ~$3 to ~$140+ per share. AMD was founded in 1969 by Jerry Sanders; key acquisitions include ATI Technologies (2006, GPUs) and Xilinx ($49 billion, 2022, FPGAs).
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.